A novel chemical delivery system for brain targeting

Area of Science:

• Neuroscience
• Pharmacology
• Medicinal Chemistry

Background:

• Effective drug delivery to the brain is a significant challenge in treating central nervous system (CNS) disorders.
• The blood-brain barrier (BBB) restricts the passage of most therapeutic agents.
• Targeting specific receptors or utilizing unique chemical reactions can overcome these delivery limitations.

Purpose of the Study:

• To review and present two distinct chemical approaches for improving drug delivery and targeting within the brain.
• To demonstrate the in vivo efficacy of these novel chemical strategies for CNS drug development.

Main Methods:

• Chemical drug delivery via a ring-closure reaction involving hydrophilic quaternary thiazolium compounds.
• Chemical drug targeting utilizing the nutrient receptor (transporter) system at the blood-brain barrier.
• Conjugation of drugs with cis-2-formylaminoethenylthio derivatives and L-glutamate (L-Glu) for enhanced brain distribution.

Main Results:

• The optimized brain delivery system successfully improved the in vivo brain delivery of drugs for Parkinson's disease, excitatory amino acid antagonists, and free radical scavengers.
• Conjugation with L-Glu enhanced drug brain distribution by leveraging L-Glu excitatory and/or transport receptors, demonstrated both in vitro and in vivo.
• Both chemical approaches show significant potential for enhancing therapeutic agent delivery across the blood-brain barrier.

Conclusions:

• The proposed chemical drug delivery and targeting strategies offer promising avenues for developing new therapeutics for CNS diseases.
• These methods provide a foundation for overcoming the challenges associated with delivering drugs to the brain.
• Further development of these chemical approaches could lead to more effective treatments for a range of neurological conditions.